发明名称 Triazolyl derivatives as Syk inhibitors
摘要 Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
申请公布号 US9586931(B2) 申请公布日期 2017.03.07
申请号 US201314431895 申请日期 2013.09.24
申请人 Merck Sharp & Dohme Corp.;Merck Canada Inc. 发明人 Machacek Michelle R.;Romeo Eric T.;Kattar Solomon D.;Christopher Matthew;Altman Michael D.;Northrup Alan B.;Ellis John Michael;O'Boyle Brendan;Donofrio Anthony;Grimm Jonathan;Reutershan Michael H.;Childers Kaleen Konrad;Otte Ryan D.;Cash Brandon;Ducharme Yves;Haidle Andrew M.;Spencer Kerrie;Vitharana Dilrukshi;Wu Lingyun;Zhang Li;Zhang Peng;Beaulieu Christian;Guay Daniel
分类号 A61K9/10;C07D401/14;C07D405/14;C07D409/14;C07D417/14;C07D498/04;C07D413/14;C07D239/42;A61K9/00;A61K9/20;A61K9/48;C07D403/12;C07D405/12;C07D409/12;C07D471/04 主分类号 A61K9/10
代理机构 代理人 Meade Eric A.;Cocuzzo Anna L.
主权项 1. A compound of Formula I:or a pharmaceutically acceptable salt thereof, wherein:is: ring a is ring b is Ya1 is CH; Yb1 is N; Yb2 is CH; R1a is independently: H, halogen, or C1-C3-alkyl; R1 is halogen;Si(CH3)3; orC1-C6-alkyl or C2-C6-alkenyl, optionally substituted with one to four substituents selected from the group consisting of: CN; OH; oxo; NH2; halogen; CO2Rc; CONH2; C1-C3-alkyl; C1-C3-haloalkyl; C1-C3-alkoxyl optionally substituted with OH or fluoro; aryl; Oaryl optionally substituted with halogen; or heterocyclyl; Heterocyclyl is a 4-, 5-, 6-, or 7-membered monocyclic ring or 8-, 9-, 10-, 11-membered bicyclic ring, or 13- or 14-membered tricyclic ring; the monocyclic, bicyclic or tricyclic ring can be saturated, unsaturated or aromatic, containing 1, 2, 3 or 4 heteroatoms selected from O, N or S, the point of attachment of the heterocyclyl can be on the carbon or nitrogen and the heterocyclyl may optionally be substituted with one to four substituents selected from CN; OH; oxo; NH2; halogen; CO(CH2)mCH3, optionally substituted with one or two substituents selected from OH and CO2Rc; C1-C3-alkyl; C2-C4-alkenyl; C1-C3-haloalkyl; C1-C3-alkoxyl optionally substituted with OH; aryl optionally substituted with one or two substituents selected from C1-C3-alkoxyl, halogen, or Oaryl; CH2aryl; OCH2aryl; Oaryl optionally substituted with one or two substituents selected from halogen; (CRaRb)nCO2Rc; (CRaRb)nCONRdRe; (CHRa)nNHCONRdRe; (CHRa)p—C(O)-heterocyclyl; and furyl; or alternatively, 2 substituents which are geminally substituted on a common ring carbon atom of said heterocyclyl may together with the common ring carbon atom form a C3-C6 spirocyclic ring; Aryl is a phenyl or napthyl ring, the aryl may optionally be substituted with one to four substituents selected from halogen, hydroxyl, C1-C3-alkyl, C1-C3-alkoxyl, Oaryl, (CRaRb)nCO2Rc; and (CRaRb)nCONRdRe; R2 is halogen, C1-C3-alkyl, or C1-C3-haloalkyl; R3 is halogen or C1-C3-fluoroalkyl; R4 is H, halogen, or C1-C3-alkyl; Ra and Rb are independently: H, OH, CN, CO2Rc, CONH2, NH2, cyclopropyl, C1-C3-haloalkyl, or C1-C3-alkyl optionally substituted with hydroxyl; Rc is: H; C1-4alkyl; -M-RCH; —(CH2)1-2—Rf; —(CH2)2—O—(CH2)2—Rf; —(CH2)2—Rg, —CHRhOCO2Ri, —CHRiRh, or —(CHRh)sOC(O)Ri; Rd and Re are independently: H, C1-C3-alkoxyl or C1-C6-alkyl, optionally substituted with one, two or three substituents CN; OH; oxo; NH2; halogen; CO2Rc; CONH2; C1-C3-alkoxyl, CO2Rc; aryl, carbocyclyl, or heterocyclyl; or cyclopropyl optionally substituted with phenyl; Rf is —OC(O)Rf1; Rf1 is C1-4alkyl; and Rg is OH, C1-4alkoxyl, NH2, NH(C1-4alkyl) or N(C1-4alkyl)2; Rh is H or C1-4alkyl; and Ri is C1-4alkyl, C3-6cycloalkyl, or phenyl; and, M is a bond or —(CH2)1-3—; RCH is (a) aryl or carbocycle optionally substituted with 1-3 groups independently selected from halo, C1-4alkyl, or C1-4alkoxy; or (b) a 5- to 6-membered monocyclic heterocycle containing 1 or 2 heteroatoms independently selected from the group consisting of N and O, wherein said heterocycle of RCH is optionally substituted with 1 or 2 groups independently selected from the group consisting of oxo and C1-3 alkyl; m is 0, 1, or 2; n is 0, 1, 2, 3 or 4; p is 0 or 1; and s is 1 or 2.
地址 Rahway NJ US